Literature DB >> 16238156

Mammography utilization in Canadian women aged 50 to 69: identification of factors that predict initiation and adherence.

Christina M Bancej1, Colleen J Maxwell, Jay Onysko, Michael Eliasziw.   

Abstract

OBJECTIVE: To identify factors that predict initiation of mammography and adherence with biennial screening among Canadian women aged 50-69 years.
METHODS: Using data from a longitudinal panel of Canadian women interviewed in the National Population Health Survey (NPHS) in 1994/95 and 2 and 4 years later, we estimated the relative risks (RR) of mammography initiation and adherence according to socio-demographic, health and lifestyle characteristics.
RESULTS: Among 505 women with no history of mammography use at baseline, 23.0% and 41.4% initiated mammography by 2 and 4 years, respectively. Urban residence (RR = 2.85) was most strongly associated with initiation by 2 years; younger age (50-54) and lower education also predicted initiation by 2 years. Younger age, birthplace outside Canada, and having a recent (< 2 years) blood pressure check were associated with initiation by 4 years. Among 873 women reporting a recent (< 2 years) mammogram at baseline, 88.7% also reported a recent mammogram within 2 years while 73.0% reported one at both the 2- and 4-year follow-up. Being a non-smoker was the strongest predictor of maintaining adherence both at the 2- (RR = 1.18) and the 4-year (RR = 1.37) follow-up.
INTERPRETATION: Previously identified underserved groups of Canadian women (e.g., those with lower educational levels or born outside of Canada) were most likely to initiate mammography. Approximately 1 in 6 women aged 50 to 69 years remained never-users during follow-up, and fewer than half reported recent mammograms at all three survey cycles, suggesting the need to reinforce regular screening participation.

Entities:  

Mesh:

Year:  2005        PMID: 16238156

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  8 in total

1.  Examining screening mammography participation among women aged 40 to 74.

Authors:  Karena D Volesky; Paul J Villeneuve
Journal:  Can Fam Physician       Date:  2017-06       Impact factor: 3.275

2.  Adherence to cancer screening guidelines across Canadian provinces: an observational study.

Authors:  Erin C Strumpf; Zhijin Chai; Srikanth Kadiyala
Journal:  BMC Cancer       Date:  2010-06-18       Impact factor: 4.430

3.  Sociodemographic determinants of nonattendance in a population-based mammography screening program in the city of Manisa, Turkey.

Authors:  Pınar Erbay Dundar; Beyhan Cengiz Ozyurt; Koray Erdurak
Journal:  ScientificWorldJournal       Date:  2012-03-12

4.  Participation and retention in the breast cancer screening program in New Brunswick Canada.

Authors:  James Ted McDonald; Yunli Wang; Zikuan Liu
Journal:  Prev Med Rep       Date:  2017-03-23

5.  Determinants of mammography screening participation-a cross-sectional analysis of the German population-based Gutenberg Health Study (GHS).

Authors:  Roman M Pokora; Matthias Büttner; Andreas Schulz; Alexander K Schuster; Hiltrud Merzenich; Andrea Teifke; Matthias Michal; Karl Lackner; Thomas Münzel; Sylke Ruth Zeissig; Philipp S Wild; Susanne Singer; Daniel Wollschläger
Journal:  PLoS One       Date:  2022-10-05       Impact factor: 3.752

6.  Factors influencing mammography participation in Canada: an integrative review of the literature.

Authors:  K Hanson; P Montgomery; D Bakker; M Conlon
Journal:  Curr Oncol       Date:  2009-09       Impact factor: 3.677

7.  Determinants of non attendance to mammography program in a region with high voluntary health insurance coverage.

Authors:  Magdalena Esteva; Joana Ripoll; Alfonso Leiva; Carmen Sánchez-Contador; Francisca Collado
Journal:  BMC Public Health       Date:  2008-11-13       Impact factor: 3.295

8.  The effect of major depression on participation in preventive health care activities.

Authors:  Scott B Patten; Jeanne V A Williams; Dina H Lavorato; Michael Eliasziw
Journal:  BMC Public Health       Date:  2009-03-25       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.